154 related articles for article (PubMed ID: 37719363)
1. Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88.
Luan C; Lu Z; Chen J; Chen M; Zhao R; Li X
Drug Des Devel Ther; 2023; 17():2821-2839. PubMed ID: 37719363
[TBL] [Abstract][Full Text] [Related]
2. Low SOCS3 expression in CD4
Lin X; Chen M; Li X; Wang H; Bao Y
Mol Immunol; 2022 Oct; 150():114-125. PubMed ID: 36030709
[TBL] [Abstract][Full Text] [Related]
3. Naringenin protects keratinocytes from oxidative stress injury via inhibition of the NOD2-mediated NF-κB pathway in pemphigus vulgaris.
Liang J; Halipu Y; Hu F; Yakeya B; Chen W; Zhang H; Kang X
Biomed Pharmacother; 2017 Aug; 92():796-801. PubMed ID: 28591691
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis is not required for acantholysis in pemphigus vulgaris.
Schmidt E; Gutberlet J; Siegmund D; Berg D; Wajant H; Waschke J
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C162-72. PubMed ID: 18987254
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.
Gil MP; Modol T; España A; López-Zabalza MJ
Exp Dermatol; 2012 Apr; 21(4):254-9. PubMed ID: 22320676
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation.
Xie Z; Dai X; Li Q; Lin S; Ye X
BMC Immunol; 2023 Nov; 24(1):43. PubMed ID: 37940861
[TBL] [Abstract][Full Text] [Related]
9. The role of nitric oxide synthases in pemphigus vulgaris in a mouse model.
Marquina M; España A; Fernández-Galar M; López-Zabalza MJ
Br J Dermatol; 2008 Jul; 159(1):68-76. PubMed ID: 18476963
[TBL] [Abstract][Full Text] [Related]
10. m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-κB pathway mediated NLRP3-ASC-Caspase1 inflammasome.
Chen Y; Cao P; Xiao Z; Ruan Z
Int Immunopharmacol; 2022 Dec; 113(Pt A):109375. PubMed ID: 36461592
[TBL] [Abstract][Full Text] [Related]
11. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
[TBL] [Abstract][Full Text] [Related]
12. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
Front Immunol; 2018; 9():1935. PubMed ID: 30233569
[TBL] [Abstract][Full Text] [Related]
13. Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88.
Zhang J; Zheng Q; Lu H; Jin F; Li Y; Bi F; Xu J
Int J Immunopathol Pharmacol; 2019; 33():2058738419857550. PubMed ID: 31204533
[TBL] [Abstract][Full Text] [Related]
14. The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?
Spindler V; Endlich A; Hartlieb E; Vielmuth F; Schmidt E; Waschke J
Am J Pathol; 2011 Oct; 179(4):1905-16. PubMed ID: 21864491
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
16. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
Ivars M; España A; Alzuguren P; Pelacho B; Lasarte JJ; López-Zabalza MJ
Br J Dermatol; 2020 May; 182(5):1194-1204. PubMed ID: 31370093
[TBL] [Abstract][Full Text] [Related]
17. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
[TBL] [Abstract][Full Text] [Related]
18. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes.
Pelacho B; Natal C; España A; Sánchez-Carpintero I; Iraburu MJ; López-Zabalza MJ
FEBS Lett; 2004 May; 566(1-3):6-10. PubMed ID: 15147859
[TBL] [Abstract][Full Text] [Related]
20. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris.
Pretel M; España A; Marquina M; Pelacho B; López-Picazo JM; López-Zabalza MJ
Exp Dermatol; 2009 Sep; 18(9):771-80. PubMed ID: 19552768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
